References
- Braman SS. The global burden of asthma. Chest 2006;130(1 Suppl):4–12S
- Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–78
- Milgrom H, Bender B, Ackerson L, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98(6 Pt 1):1051–7
- Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 2006;141:189–98
- Strek ME. Difficult asthma. Proc Am Thorac Soc 2006;3:116–23
- Sussman R. Identifying chronic obstructive pulmonary disease in patients with respiratory symptoms. Curr Med Res Opin 2007;23(Suppl 3):S5–12
- Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998;12:1209–18
- Blaiss MS. Inhaler technique and adherence to therapy. Curr Med Res Opin 2007;23(Suppl 3):S13–20
- Barnes PJ. Introduction: how can we improve asthma management? Curr Med Res Opin 2005;21(Suppl 4):S1–3
- Tulic MK, Hamid Q. New insights into the pathophysiology of the small airways in asthma. Clin Chest Med 2006;27:41–52
- Kraft M. Location of asthma inflammation and the distal airways: clinical implications. Curr Med Res Opin 2007;23(Suppl 3):S21–7
- Vanden Burgt JA, Busse WW, Martin RJ, et al. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000;106:1209–26
- Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104:1215–22
- Peters S. Genetic variations in β2-adrenergic receptors: long-acting and short-acting β2-agonists and therapeutic response. Curr Med Res Opin 2007;23(Suppl 3):S29–36
- Israel E, Drazen JM, Liggett SB, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000;162:75–80
- Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 2000;55:762–7
- Israel E, Chinchilli VM, Ford JG, et al., for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505–12
- Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129:15–26
- Cloosterman SG, Bijl-Hofland ID, van Herwaarden CL, et al. A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients. Chest 2001;119:1306–15